alibaba health information technology ltd. - ALBHF

ALBHF

Close Chg Chg %
0.67 -0.00 -0.61%

Closed Market

0.67

0.00 (0.61%)

Volume: 500.00

Last Updated:

May 20, 2025, 9:30 AM EDT

Company Overview: alibaba health information technology ltd. - ALBHF

ALBHF Key Data

Open

$0.67

Day Range

0.67 - 0.67

52 Week Range

0.32 - 0.80

Market Cap

$10.77B

Shares Outstanding

16.08B

Public Float

5.05B

Beta

0.84

Rev. Per Employee

N/A

P/E Ratio

54.14

EPS

N/A

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

96.14

 

ALBHF Performance

No Data Available

ALBHF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About alibaba health information technology ltd. - ALBHF

Alibaba Health Information Technology Ltd. is an investment holding company, which engages in the provision of Internet technology, service tools, and platforms to offer medical and healthcare services. Its activities include self-operated healthcare product sales, e-commerce platform services, tracking services, and innovative healthcare related services and others. The company was founded on March 11, 1998 and is headquartered in Hong Kong.

ALBHF At a Glance

Alibaba Health Information Technology Ltd.
26/F, Tower One
Hong Kong,
Phone 852-2583-9333 Revenue 4.24B
Industry Information Technology Services Net Income 198.44M
Sector Technology Services 2025 Sales Growth 12.476%
Fiscal Year-end 03 / 2026 Employees 1,364
View SEC Filings

ALBHF Valuation

P/E Current 54.138
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 49.217
Price to Sales Ratio 2.304
Price to Book Ratio N/A
Price to Cash Flow Ratio 50.544
Enterprise Value to EBITDA 40.943
Enterprise Value to Sales 2.032
Total Debt to Enterprise Value 0.001

ALBHF Efficiency

Revenue/Employee 3,107,744.927
Income Per Employee 145,485.825
Receivables Turnover 29.206
Total Asset Turnover 1.501

ALBHF Liquidity

Current Ratio 2.589
Quick Ratio 2.29
Cash Ratio 1.772

ALBHF Profitability

Gross Margin 24.289
Operating Margin 4.775
Pretax Margin 5.31
Net Margin 4.681
Return on Assets 7.028
Return on Equity 9.313
Return on Total Capital 8.803
Return on Invested Capital 9.291

ALBHF Capital Structure

Total Debt to Total Equity 0.218
Total Debt to Total Capital 0.217
Total Debt to Total Assets 0.168
Long-Term Debt to Equity 0.153
Long-Term Debt to Total Capital 0.153
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Alibaba Health Information Technology Ltd. - ALBHF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
3.21B 3.90B 3.77B 4.24B
Sales Growth
+40.09% +21.74% -3.45% +12.48%
Cost of Goods Sold (COGS) incl D&A
2.57B 3.07B 2.95B 3.21B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
9.44M 9.29M 7.49M 7.98M
Depreciation
7.58M 6.74M 5.12M 5.65M
Amortization of Intangibles
1.86M 2.55M 2.36M 2.33M
COGS Growth
+46.21% +19.70% -4.08% +8.91%
Gross Income
640.14M 831.57M 822.09M 1.03B
Gross Income Growth
+19.98% +29.90% -1.14% +25.24%
Gross Profit Margin
+19.96% +21.30% +21.81% +24.29%
2022 2023 2024 2025 5-year trend
SG&A Expense
810.71M 838.15M 733.53M 825.64M
Research & Development
113.57M 98.86M 98.36M 99.75M
Other SG&A
697.14M 739.29M 635.17M 725.89M
SGA Growth
+54.75% +3.38% -12.48% +12.56%
Other Operating Expense
- - - 1.55M
-
Unusual Expense
(24.62M) (4.07M) 49.72M 49.12M
EBIT after Unusual Expense
(145.95M) (2.51M) 38.84M 153.30M
Non Operating Income/Expense
114.31M 82.07M 93.82M 72.13M
Non-Operating Interest Income
32.70M 48.36M 67.50M 64.40M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
594.48K 850.78K 832.36K 361.44K
Interest Expense Growth
+64.58% +43.11% -2.16% -56.58%
Gross Interest Expense
594.48K 850.78K 832.36K 361.44K
Interest Capitalized
- - - -
-
Pretax Income
(32.24M) 78.71M 131.82M 225.07M
Pretax Income Growth
-149.72% +344.12% +67.49% +70.74%
Pretax Margin
-1.01% +2.02% +3.50% +5.31%
Income Tax
2.09M 2.44M 7.85M 17.73M
Income Tax - Current - Domestic
- 5.38M 4.55M 11.80M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- (3.29M) (2.11M) (3.96M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(41.44M) 77.93M 123.15M 198.39M
Minority Interest Expense
(60.15K) 124.85K (47.55K) (57.22K)
Net Income
(41.38M) 77.80M 123.20M 198.44M
Net Income Growth
-180.48% +288.01% +58.35% +61.08%
Net Margin Growth
-1.29% +1.99% +3.27% +4.68%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(41.38M) 77.80M 123.20M 198.44M
Preferred Dividends
- - - -
-
Net Income Available to Common
(41.38M) 77.80M 123.20M 198.44M
EPS (Basic)
-0.0031 0.0058 0.0088 0.0123
EPS (Basic) Growth
-179.49% +287.10% +51.72% +39.77%
Basic Shares Outstanding
13.48B 13.50B 14.04B 16.07B
EPS (Diluted)
-0.0031 0.0057 0.0087 0.0123
EPS (Diluted) Growth
-179.49% +283.87% +52.63% +41.38%
Diluted Shares Outstanding
13.48B 13.54B 14.09B 16.14B
EBITDA
(161.13M) 2.71M 96.04M 210.40M
EBITDA Growth
-1,398.92% +101.68% +3,442.03% +119.08%
EBITDA Margin
-5.03% +0.07% +2.55% +4.96%

Alibaba Health Information Technology Ltd. in the News